Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp (AHCO) delivers essential home medical equipment and healthcare-at-home services, empowering patients through respiratory care, mobility solutions, and chronic condition management. This page provides centralized access to all official company announcements and market-relevant developments.
Investors and healthcare professionals will find timely updates on earnings reports, regulatory milestones, product launches, and strategic partnerships. Our curated collection includes press releases on sleep therapy innovations, respiratory equipment advancements, and operational expansions across AHCO's nationwide network.
Key areas covered include quarterly financial results, clinical service enhancements, Medicare/Medicaid compliance updates, and technology integrations in home healthcare. All content is sourced directly from AdaptHealth's communications to ensure accuracy and relevance for stakeholders.
Bookmark this page for streamlined access to AHCO's latest business developments. Check regularly for updates impacting the home healthcare sector and AdaptHealth's position within this critical industry.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its third quarter 2022 financial results before the market opens on November 8, 2022. Management will hold a teleconference at 8:30 a.m. ET to discuss the results and ongoing business activities with analysts and investors. AdaptHealth is a leader in providing healthcare-at-home solutions, serving around 3.9 million patients annually through over 750 locations in 47 states, focusing on home medical equipment, medical supplies, and related services.
AdaptHealth Corp. (NASDAQ: AHCO) announced new long-term financial goals during its 2022 Capital Markets Day. CEO Steve Griggs highlighted the company's progress in establishing a scalable foundation for profitable growth and shareholder value. The company aims to lead the shift to connected in-home healthcare, emphasizing its commitment to cost-effective patient care. AdaptHealth serves approx. 3.9 million patients annually, leveraging operational excellence and strategic acquisitions. The firm is focused on enhancing its chronic disease management programs and expanding its connected care offerings.
AdaptHealth Corp. (NASDAQ: AHCO) will host its first Capital Markets Day on September 16, 2022, at 9:00 a.m. ET. The event aims to present the Company’s business model, market position, and long-term strategies for growth and profitability. CEO Steve Griggs emphasizes the importance of connecting with investors and analysts. The event will be webcast live, with additional materials available on AdaptHealth’s website. This initiative reflects AdaptHealth's commitment to providing healthcare-at-home solutions and reaching approximately 3.9 million patients annually across the U.S.
AdaptHealth Corp. (NASDAQ: AHCO) reported second-quarter financial results for 2022, highlighting a net revenue of $727.6 million, a 17.9% increase from $617.0 million in 2021. Adjusted EBITDA rose 1.8% to $150.0 million, with an EBITDA margin improvement to 20.6%. However, net income dropped to $14.0 million from $79.1 million year-over-year. Non-acquired net revenue slightly decreased by 0.3%. The company maintained its 2022 guidance, projecting net revenue between $2.840 billion and $3.040 billion.
AdaptHealth Corp. (NASD: AHCO) will be added to the S&P SmallCap 600 index, effective August 4, 2022. This change comes as Cummins Inc. (NYSE: CMI) is acquiring Meritor Inc. (NYSE: MTOR), which is being removed from the index. The transition reflects a strategic reshuffle in the S&P indices as AdaptHealth enhances its presence in the health care sector. The acquisition of Meritor by Cummins is expected to complete soon, pending closing conditions.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its Q2 2022 financial results before market open on
AdaptHealth Corp. (NASDAQ: AHCO) has announced that
AdaptHealth is a leader in providing patient-centered healthcare-at-home solutions, serving approximately 3.9 million patients annually across the United States.
AdaptHealth Corp. (NASDAQ: AHCO) will participate in a fireside chat at the UBS Global Healthcare Conference on May 25, 2022, at 10:00 am ET. President Josh Parnes and CFO Jason Clemens will represent the Company, a leader in patient-centered healthcare-at-home solutions. Interested parties can access a live webcast on AdaptHealth's website. The Company serves around 3.9 million patients annually through over 750 locations nationwide, offering medical equipment and services designed for chronic condition management.
AdaptHealth Corp. (NASDAQ: AHCO) announced participation in a fireside chat at the RBC Capital Markets 2022 Global Healthcare Conference on May 17, 2022, at 10:30 am ET. President Josh Parnes and CFO Jason Clemens will represent the company. A live webcast will be available on AdaptHealth’s website, which should be accessed 5-10 minutes before the session. AdaptHealth is a leader in patient-centered healthcare-at-home solutions, serving approximately 3.9 million patients annually across the U.S.
AdaptHealth Corp. (NASDAQ: AHCO) announced strong financial results for Q1 2022, with net revenue of $706.2 million, a 46.5% increase from the previous year. Adjusted EBITDA rose 32.1% to $137.6 million. The company reported a net income of $41.8 million compared to a net loss of $4.0 million in Q1 2021. A share repurchase program for up to $200 million was authorized, reflecting confidence in the company's outlook. AdaptHealth has continued to address challenges from CPAP equipment shortages and has completed six acquisitions this year, with updated revenue guidance for 2022 between $2.840 billion and $3.040 billion.
FAQ
What is the current stock price of Adapthealth (AHCO)?
What is the market cap of Adapthealth (AHCO)?
